We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+31.11%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$3.29B
AUM Growth
+$954M
Cap. Flow
+$337M
Cap. Flow %
10.25%
Top 10 Hldgs %
20.49%
Holding
135
New
9
Increased
113
Reduced
10
Closed
3

Sector Composition

Rank Sector Weight
1 Industrials 19.71%
2 Technology 16.05%
3 Healthcare 15.69%
4 Financials 12.98%
5 Consumer Discretionary 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCN icon
51
FTI Consulting
FCN
$4.4B
$24.3M 0.74%
212,330
+19,285
+10% +$2.33M
WAB icon
52
Wabtec
WAB
$49.1B
$23.8M 0.72%
413,836
+98,668
+31% +$5.59M
AEL
53
DELISTED
American Equity Investment Life Holding Company
AEL
$23.6M 0.72%
954,483
+90,224
+10% +$1.88M
NUS icon
54
Nu Skin
NUS
$252M
$23.4M 0.71%
612,346
+79,262
+15% +$2.55M
CNS icon
55
Cohen & Steers
CNS
$4.23B
$23.4M 0.71%
343,244
-3,567
-1% -$215K
USX
56
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$23M 0.7%
3,830,598
+492,139
+15% +$2.25M
CMCO icon
57
Columbus McKinnon
CMCO
$553M
$22.7M 0.69%
679,402
+77,699
+13% +$2.14M
NDAQ icon
58
Nasdaq
NDAQ
$52.7B
$22.5M 0.68%
564,192
-219,450
-28% -$8.17M
CAMP
59
DELISTED
CalAmp Corp.
CAMP
$22.2M 0.68%
120,602
+15,412
+15% +$2.38M
IWN icon
60
iShares Russell 2000 Value ETF
IWN
$14.3B
$22.1M 0.67%
226,351
+1,737
+0.8% +$158K
SP
61
DELISTED
SP Plus Corporation
SP
$21.6M 0.66%
1,044,879
+102,152
+11% +$2.11M
MATW icon
62
Matthews International
MATW
$866M
$21.6M 0.66%
1,132,609
+104,214
+10% +$2.22M
ATNI icon
63
ATN International
ATNI
$366M
$21.6M 0.66%
357,092
+39,705
+13% +$2.38M
MD icon
64
Pediatrix Medical
MD
$2.18B
$21.1M 0.64%
1,234,383
+162,589
+15% +$2.41M
EVR icon
65
Evercore
EVR
$12.4B
$20.4M 0.62%
+346,645
New +$18.9M
HURN icon
66
Huron Consulting
HURN
$2.41B
$20.1M 0.61%
453,395
+190,044
+72% +$8.56M
PACW
67
DELISTED
PacWest Bancorp
PACW
$19.8M 0.6%
1,002,304
+87,239
+10% +$1.62M
CAI
68
DELISTED
CAI International, Inc.
CAI
$19.1M 0.58%
1,146,052
+106,009
+10% +$1.77M
IEX icon
69
IDEX
IEX
$17B
$18.9M 0.57%
119,425
+12,133
+11% +$1.85M
FLIR
70
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$18.8M 0.57%
463,793
+44,165
+11% +$1.83M
B
71
DELISTED
Barnes Group Inc.
B
$18.7M 0.57%
472,374
+59,563
+14% +$2.29M
UMPQ
72
DELISTED
Umpqua Holdings Corp
UMPQ
$18.1M 0.55%
1,705,339
-91,045
-5% -$1.02M
CCRN
73
DELISTED
Cross Country Healthcare
CCRN
$17.9M 0.55%
2,913,237
+293,248
+11% +$1.8M
AZZ icon
74
AZZ Inc
AZZ
$4.35B
$17.9M 0.54%
521,258
+91,337
+21% +$2.79M
ATR icon
75
AptarGroup
ATR
$8.55B
$17.7M 0.54%
157,825
+12,214
+8% +$1.3M

Similar funds

Aristotle Capital Boston's Q2 2020 Portfolio in Review

As of Q2 2020, Aristotle Capital Boston held 135 positions worth $3.29B, up 41% from $2.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Aristotle Capital Boston deployed $337M of net new capital in Q2 2020, opening 9 new positions and adding to 113 existing holdings. Its largest new stake was Pacific Premier Bancorp: 2,156,731 shares worth $46.8M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was QuidelOrtho, an estimated $21.1M trimmed.

  • Aristotle Capital Boston's largest Q2 2020 buy was Pacific Premier Bancorp: 2,156,731 shares worth $46.8M.
  • Aristotle Capital Boston added most to iShares Core S&P Small-Cap ETF in Q2 2020, an estimated $9.3M increase.
  • Aristotle Capital Boston's biggest Q2 2020 reduction was QuidelOrtho, cutting an estimated $21.1M.
  • Aristotle Capital Boston fully exited Opus Bank Common Stock in Q2 2020, selling an estimated $37.9M.
  • Aristotle Capital Boston's ten largest holdings make up 20% of its $3.29B portfolio in Q2 2020.
  • Aristotle Capital Boston opened 9 new positions and closed 3 in Q2 2020.
  • Aristotle Capital Boston's portfolio value rose 41% quarter-over-quarter to $3.29B.

Based on Aristotle Capital Boston's 13F filing for Q2 2020, filed 14 Aug 2020.